A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
|
2026. Április 29. Péter napja van
2026. Április 29. Péter napja van
A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.
|
